ID   CA-HPV-10
AC   CVCL_3495
SY   Ca-HPV-10; CA-HPV10; CaHPV10; HPV10
DR   BTO; BTO_0003464
DR   CLO; CLO_0002174
DR   EFO; EFO_0002147
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2220
DR   BCRC; 60135
DR   BioSample; SAMN03472568
DR   cancercelllines; CVCL_3495
DR   Cosmic; 1071479
DR   GEO; GSM648817
DR   IGRhCellID; CaHPV10
DR   Progenetix; CVCL_3495
DR   Wikidata; Q54808293
RX   PubMed=7923200;
RX   PubMed=11135431;
RX   PubMed=12725112;
RX   PubMed=20215515;
RX   PubMed=21544329;
WW   https://web.archive.org/web/20150602153453/http://capcelllines.ca:80/details.asp?id=83
CC   Population: Caucasian.
CC   Doubling time: 38.44 hours (JWGray panel).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2220
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 13
ST   D21S11: 28,31
ST   D2S1338: 16,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 8,16
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
RX   PubMed=7923200;
RA   Weijerman P.C., Konig J.J., Wong S.T., Niesters H.G.M., Peehl D.M.;
RT   "Lipofection-mediated immortalization of human prostatic epithelial
RT   cells of normal and malignant origin using human papillomavirus type
RT   18 DNA.";
RL   Cancer Res. 54:5579-5583(1994).
//
RX   PubMed=11135431; DOI=10.1002/1098-2264(2000)9999:9999<::AID-GCC1076>3.0.CO;2-E;
RA   Aurich-Costa J., Vannier A., Gregoire E., Nowak F., Cherif D.;
RT   "IPM-FISH, a new M-FISH approach using IRS-PCR painting probes:
RT   application to the analysis of seven human prostate cell lines.";
RL   Genes Chromosomes Cancer 30:143-160(2001).
//
RX   PubMed=12725112; DOI=10.1385/1-59259-372-0:21;
RA   Russell P.J., Kingsley E.A.;
RT   "Human prostate cancer cell lines.";
RL   Methods Mol. Med. 81:21-39(2003).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=21544329; DOI=10.3892/ijo.8.1.41;
RA   Gross C., Skowronski R.J., Plymate S.R., Rhim J.S., Peehl D.M.,
RA   Feldman D.;
RT   "Simian virus 40-, but not human papillomavirus-, transformation of
RT   prostatic epithelial cells results in loss of growth-inhibition by
RT   1,25-dihydroxyvitamin D-3.";
RL   Int. J. Oncol. 8:41-47(1996).
//